Eva Segelov

Eva Segelov

St Vincent's Hospital
Darlinghurst, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Target trial emulation: bridging observational studies and randomized trials for health decision-making.

Target trial emulation: bridging observational studies and randomized trials for health decision-making.

Journal: Journal of comparative effectiveness research

Published: March 19, 2026

Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis.

Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis.

Journal: EBioMedicine

Published: February 05, 2026

Patients' perspective in anal cancer.

Patients' perspective in anal cancer.

Journal: ESMO gastrointestinal oncology

Published: July 11, 2025

An approach to implementing patient and public involvement in investigator-initiated clinical trials.

An approach to implementing patient and public involvement in investigator-initiated clinical trials.

Journal: Swiss medical weekly

Published: June 26, 2025

SRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss.

SRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 10, 2025

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Journal: JCO oncology practice

Published: February 27, 2025

The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 24, 2025

Incidence and burden of anal cancer-time to fight the growing disparities.

Incidence and burden of anal cancer-time to fight the growing disparities.

Journal: ESMO gastrointestinal oncology

Published: February 24, 2025

An overview of clinical trials in anal cancer 1999-2024.

An overview of clinical trials in anal cancer 1999-2024.

Journal: ESMO gastrointestinal oncology

Published: February 17, 2025

Immune Response to COVID-19 Vaccination in Children With Cancer.

Immune Response to COVID-19 Vaccination in Children With Cancer.

Journal: Pediatrics

Published: December 02, 2024

AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).

AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).

Journal: Clinical colorectal cancer

Published: October 14, 2024

Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022.

Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022.

Journal: JCO global oncology

Published: October 03, 2024

Showing 1-12 of 137

Last Updated: 09/26/2026